These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 16840428)

  • 1. Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.
    Kaka AS; Rueda AM; Shelburne SA; Hulten K; Hamill RJ; Musher DM
    J Antimicrob Chemother; 2006 Sep; 58(3):680-3. PubMed ID: 16840428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus.
    Leonard SN; Kaatz GW; Rucker LR; Rybak MJ
    J Antimicrob Chemother; 2008 Dec; 62(6):1305-10. PubMed ID: 18801920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility and staphylococcal chromosomal cassette mec type in community- and hospital-associated methicillin-resistant Staphylococcus aureus.
    LaPlante KL; Rybak MJ; Amjad M; Kaatz GW
    Pharmacotherapy; 2007 Jan; 27(1):3-10. PubMed ID: 17192156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents.
    Tsuji BT; Rybak MJ; Cheung CM; Amjad M; Kaatz GW
    Diagn Microbiol Infect Dis; 2007 May; 58(1):41-7. PubMed ID: 17300912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
    Arnold FW; Wojda B
    J Ky Med Assoc; 2005 May; 103(5):206-10. PubMed ID: 15918650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methicillin-resistant Staphylococcus aureus (MRSA) in the community].
    Vonk AG; Vandenbroucke-Grauls CM
    Ned Tijdschr Geneeskd; 2007 Feb; 151(7):401-7. PubMed ID: 17343138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative activity of telavancin against isolates of community-associated methicillin-resistant Staphylococcus aureus.
    Saravolatz LD; Pawlak J; Johnson LB
    J Antimicrob Chemother; 2007 Aug; 60(2):406-9. PubMed ID: 17586562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility and clonal relatedness between community- and hospital-acquired methicillin-resistant Staphylococcus aureus from blood cultures.
    Jung SI; Shin DH; Park KH; Shin JH
    J Microbiol; 2006 Jun; 44(3):336-43. PubMed ID: 16820764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients.
    Skiest DJ; Brown K; Cooper TW; Hoffman-Roberts H; Mussa HR; Elliott AC
    J Infect; 2007 May; 54(5):427-34. PubMed ID: 17070598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of community-acquired Staphylococcus aureus infections in children.
    Johnson PN; Rapp RP; Nelson CT; Butler JS; Overman S; Kuhn RJ
    Ann Pharmacother; 2007 Sep; 41(9):1361-7. PubMed ID: 17652124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolution of Staphylococcus aureus.
    Deurenberg RH; Stobberingh EE
    Infect Genet Evol; 2008 Dec; 8(6):747-63. PubMed ID: 18718557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal spread of SCCmec type IV methicillin-resistant Staphylococcus aureus between community and hospital.
    Huang YH; Tseng SP; Hu JM; Tsai JC; Hsueh PR; Teng LJ
    Clin Microbiol Infect; 2007 Jul; 13(7):717-24. PubMed ID: 17403129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-acquired MRSA infections in North Carolina children: prevalence, antibiotic sensitivities, and risk factors.
    Shapiro A; Raman S; Johnson M; Piehl M
    N C Med J; 2009; 70(2):102-7. PubMed ID: 19489364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance in clinical isolates of Staphylococcus aureus from hospital and community sources in southern Jamaica.
    Brown PD; Ngeno C
    Int J Infect Dis; 2007 May; 11(3):220-5. PubMed ID: 16815064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Lawrence KR; Golik MV; Davidson L
    Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of honey against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA).
    Maeda Y; Loughrey A; Earle JA; Millar BC; Rao JR; Kearns A; McConville O; Goldsmith CE; Rooney PJ; Dooley JS; Lowery CJ; Snelling WJ; McMahon A; McDowell D; Moore JE
    Complement Ther Clin Pract; 2008 May; 14(2):77-82. PubMed ID: 18396250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethoprim-sulfamethoxazole plus topical antibiotics as therapy for acute otitis media with otorrhea caused by community-acquired methicillin-resistant Staphylococcus aureus in children.
    Al-Shawwa BA; Wegner D
    Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):782-4. PubMed ID: 16172354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureus.
    Huang V; Cheung CM; Kaatz GW; Rybak MJ
    Int J Antimicrob Agents; 2010 Jan; 35(1):25-9. PubMed ID: 19900792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity of tigecycline against community-acquired methicillin-resistant Staphylococcus aureus isolates recovered from North American medical centers.
    Mendes RE; Sader HS; Deshpande L; Jones RN
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):433-6. PubMed ID: 18068326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.